Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...
The department used its new system for determining whether a condition is service-connected to give affected veterans access ...
The National Cancer Institute estimates that in the United States, slightly over 35,000 people will be diagnosed with multiple myeloma by the end of 2024 ... The early stages of kidney disease ...
Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...
News Medical on MSN1d
Interactive atlas unveils immune changes in multiple myelomaMultiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...
GSK reported positive results from its phase three ‘DREAMM-7’ trial on Thursday, highlighting a significant overall survival ...
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
More information: Emma Verheye et al, A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages, Journal of Hematology & Oncology (2024).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback